Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients - Takeaways - MDSpire

Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients

  • By

  • Jan Krhut

  • Pavel Hradílek

  • Adéla Kondé

  • Barbora Skugarevská

  • Ivana Woznicová

  • Radek Paus Sýkora

  • Hanne Kobberø

  • Tomáš Rychlý

  • Peter Zvara

  • May 31, 2025

  • 0 min

Share

  • 1

    Multiple sclerosis (MS) affects approximately 2.8 million individuals globally and significantly impacts their daily lives.

  • 2

    Lower urinary tract symptoms (LUTS) are prevalent in 32% to 96.8% of patients with MS, affecting social activities and work performance.

  • 3

    The study aimed to determine the onset timing of LUTS in MS patients and identify risk factors for early development.

  • 4

    In the analyzed cohort, 61% of patients reported LUTS, with urgency being the most common first symptom.

  • 5

    Higher age, greater disability, and specific clinical features were linked to shorter LUTS-free survival in MS patients.

Original Source(s)

Analysis of the onset of lower urinary tract symptoms in multiple scleroris patients

  • by Jan Krhut, Pavel Hradílek, Adéla Kondé, Barbora Skugarevská, Ivana Woznicová, Radek Paus Sýkora, Hanne Kobberø, Tomáš Rychlý, Peter Zvara

  • May 31, 2025

Related Content

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

Oral BTK Inhibitor Shows Disability Benefit in Progressive Multiple Sclerosis Trial

Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS

  • February 17, 2026

  • 3 min
CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

  • March 11, 2026

  • 3 min